Pilot Study of Cabozantinib for Recurrent or Progressive High-Grade Glioma in Children
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Cabozantinib (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 19 May 2017 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.
- 19 May 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 19 May 2017 Status changed from not yet recruiting to recruiting.